Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1311388.RAh_IngNZbLLoulBYFF5Spf6y54sNMzzUrLbggVAJl2Fg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1311388.RAh_IngNZbLLoulBYFF5Spf6y54sNMzzUrLbggVAJl2Fg130_assertion type Assertion NP1311388.RAh_IngNZbLLoulBYFF5Spf6y54sNMzzUrLbggVAJl2Fg130_head.
- NP1311388.RAh_IngNZbLLoulBYFF5Spf6y54sNMzzUrLbggVAJl2Fg130_assertion description "[In addition to a strong expression of CD44s, variant isoforms containing CD44-6v in combination with other variant exons were observed predominantly in aggressive lymphoma and were associated with a shorter overall survival of patients (n = 138; P < .0001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311388.RAh_IngNZbLLoulBYFF5Spf6y54sNMzzUrLbggVAJl2Fg130_provenance.
- NP1311388.RAh_IngNZbLLoulBYFF5Spf6y54sNMzzUrLbggVAJl2Fg130_assertion evidence source_evidence_literature NP1311388.RAh_IngNZbLLoulBYFF5Spf6y54sNMzzUrLbggVAJl2Fg130_provenance.
- NP1311388.RAh_IngNZbLLoulBYFF5Spf6y54sNMzzUrLbggVAJl2Fg130_assertion SIO_000772 7537983 NP1311388.RAh_IngNZbLLoulBYFF5Spf6y54sNMzzUrLbggVAJl2Fg130_provenance.
- NP1311388.RAh_IngNZbLLoulBYFF5Spf6y54sNMzzUrLbggVAJl2Fg130_assertion wasDerivedFrom befree-2016 NP1311388.RAh_IngNZbLLoulBYFF5Spf6y54sNMzzUrLbggVAJl2Fg130_provenance.
- NP1311388.RAh_IngNZbLLoulBYFF5Spf6y54sNMzzUrLbggVAJl2Fg130_assertion wasGeneratedBy ECO_0000203 NP1311388.RAh_IngNZbLLoulBYFF5Spf6y54sNMzzUrLbggVAJl2Fg130_provenance.